Search Results - "Amandzholov, B. S."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Mononuclear Leukocytes from Mice with Resected Tumor Induce Resistance to Transplantation of Tumor Cells to Animals by Sitdikova, S. M, Kiselevskii, M. V, Sel'chuk, V. Yu, Amandzholov, B. S, Voyushin, K. E, Luchenko, I. M, Donenko, F. V

    “…Experiments on male C57Bl/6 mice with intraperitoneally transplanted Ehrlich carcinoma and DBA/2 mice with subcutaneously transplanted S-91 melanoma showed…”
    Get full text
    Journal Article
  2. 2

    INFLUENCE OF METRONIDAZOLE ON BIOLOGICAL ACTION OF DOXORUBICIN by S. A. Yagubov, B. S. Amandzholov, F. V. Donenko, Yu. I. Dolzhikova, N. V. Malakhova

    Published in Issledovaniâ i praktika v medicine (21-09-2017)
    “…Purpose. Investigation of the effect of the Metronizatol on the biological effect of Doxirubicin.Materials and methods. The studies were performed in the…”
    Get full text
    Journal Article
  3. 3

    Lectin binding to mouse blood lymphocytes during tumor growth by Sitdikova, S M, Amandzholov, B S, Kiselevskii, M V, Donenko, F V

    “…Binding of FITC-labeled lectins to lymphocytes from intact mice and mice with transplanted Ehrlich carcinoma and CaO-1 ovarian carcinoma was studied by flow…”
    Get full text
    Journal Article
  4. 4

    Partial elimination of lymphocytes in mice with Ehrlich carcinoma by Sitdikova, S M, Amandzholov, B S, Donenko, F V

    “…Elimination of about 30% lymphocyte population was observed in female Balb/c mice on day 11 after transplantation of Ehrlich carcinoma in comparison with…”
    Get full text
    Journal Article
  5. 5

    Induction of resistance to murine tumor development is associated with alterations in the glycosylation of blood serum proteins by Donenko, F V, Ziganshin, R K, Sitdikova, S M, Amandzholov, B S, Kiselevskii, M V, Efferth, T

    Published in Molecular medicine reports (01-05-2009)
    “…The phenomenon of accelerated metastatic tumor growth following the removal of the primary tumor is a major reason for cancer relapse, caused by underlying…”
    Get full text
    Journal Article
  6. 6

    Identification of Serpin (a-1-Antitrypsin) as Serum Growth Inhibitory Factor in Murine Ehrlich Carcinoma by Proteomics by Donenko, F V, Ziganshin, R H, Anisimova, N Y, Voyushin, KE, Sitdikova, S M, Amandzholov, B S, Kiselevskii, M V, Efferth, T

    Published in Cancer genomics & proteomics (01-06-2010)
    “…It is well established that serum factors play a role in relapse of tumor diseases after removal of the primary tumor. The molecular nature of these factors…”
    Get full text
    Journal Article
  7. 7

    Evaluation of Immunotherapy Efficiency in Mouse CaO-1 Ovarian Carcinoma Treated by Vaccines Based on Dendritic Cells by Sitdikova, S. M., Kiselevskii, M. V., Sel’chuk, V. Yu, Amandzholov, B. S., Kurbatova, E. A., Donenko, F. V.

    “…Injection of dendritic cells, pulsated by tumor lysate or mucin, containing CA 125 antigen, led to a more than 50% inhibition of tumor growth in female CBA…”
    Get full text
    Journal Article
  8. 8

    Specificity of relapses and metastases of experimental transplanted Ehrlich carcinoma and B16 melanoma by Sitdikova, S M, Amandzholov, B S, Kiselevskii, M V, Donenko, F V

    “…Experiments on female (CBAxC57Bl/6)F1 mice with simultaneously transplanted Ehrlich carcinoma and B16 melanoma showed that removal of one of the primary nodes…”
    Get full text
    Journal Article
  9. 9

    Antitumor activity of specific immunotherapy with mucin containing CA 125 antigen in mice with CaO 1 ovarian carcinoma by Amandzholov, B S, Sitdikova, S M, Lebedin, Y S, Chukanov, S V, Toptygin, A Y, Manzyuk, L V, Donenko, F V

    “…Experiments in CBA mice with transplanted CaO 1 ovarian carcinoma possessing common antigenic determinants with human ovarian carcinoma showed that specific…”
    Get full text
    Journal Article
  10. 10

    Biological activity of hemoglobin-containing complex isolated from blood serum of mice with Ehrlich carcinoma by Donenko, F V, Sitdikova, S M, Amandzholov, B S, Kiselevskii, M V

    “…Injection of hemoglobin-containing complex of serum proteins isolated from animals with Ehrlich carcinoma led to regression of intraperitoneally and…”
    Get full text
    Journal Article
  11. 11

    Immunotoxicological characteristics of preparations based on carcinoembryonic antigen and mucin containing CA 125 antigen by Sitdikova, S M, Amandzholov, B S, Sel'chuk, V Y, Kormosh, N G, Laktionov, K P, Lebedin, Y S, Chukanov, S V, Toptygin, A Y, Manzyuk, L V, Donenko, F V

    “…Experiments on male hybrid mice demonstrated that specific immunotherapy with preparations based on carcinoembryonal antigen and mucin containing CA 125…”
    Get full text
    Journal Article
  12. 12

    Peculiarities of hemoglobin interaction with serum proteins of mice with Ehrlich carcinoma by Sitdikova, S M, Amandzholov, B S, Serebryakova, M V, Zhdanovich, M Yu, Kiselevskii, M V, Donenko, F V

    “…In male C57Bl/6 mice with transplanted Ehrlich carcinoma, hemoglobin forms a complex with serum proteins characterized by a molecular weight of about 300 kDa…”
    Get full text
    Journal Article
  13. 13

    Interactions between natural autoantibodies to tumor-associated human ovarian cancer antigen and murine ovarian cancer cells CaO-1 by Amandzholov, B. S., Lebedin, Yu. S., Chukanov, S. V., Toptygin, A. Yu, Sitdikova, S. M., Moroz, L. L., Manyuk, L. V., Donenko, F. V.

    “…The interactions between tumor cells and autoantibodies to tumor-associated human ovarian cancer antigen isolated from the plasma of a non-cancer patient are…”
    Get full text
    Journal Article
  14. 14

    Tumor-specific changes in mouse serum during Ehrlich carcinoma growth by Sitdikova, S M, Amandzholov, B S, Sel'chuk, V Yu, Donenko, F V

    “…Using the method of flow cytofluorometry we found that proteinase activity eliminating antigenic determinants from the surface of tumor cells disappeared from…”
    Get full text
    Journal Article
  15. 15

    Identification of serpin (alpha-1-antitrypsin) as serum growth inhibitory factor in murine ehrlich carcinoma by proteomics by Donenko, F V, Ziganshin, R H, Anisimova, N Yu, Voyushin, K E, Sitdikova, S M, Amandzholov, B S, Kiselevskii, M V, Efferth, T

    Published in Cancer genomics & proteomics (01-05-2010)
    “…It is well established that serum factors play a role in relapse of tumor diseases after removal of the primary tumor. The molecular nature of these factors…”
    Get more information
    Journal Article
  16. 16
  17. 17